Emily K. Law

2.9k total citations · 1 hit paper
20 papers, 1.7k citations indexed

About

Emily K. Law is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Emily K. Law has authored 20 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Emily K. Law's work include Cancer Genomics and Diagnostics (7 papers), CRISPR and Genetic Engineering (6 papers) and Epigenetics and DNA Methylation (6 papers). Emily K. Law is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), CRISPR and Genetic Engineering (6 papers) and Epigenetics and DNA Methylation (6 papers). Emily K. Law collaborates with scholars based in United States, Netherlands and United Kingdom. Emily K. Law's co-authors include Reuben S. Harris, William L. Brown, Lela Lackey, Michael A. Carpenter, Nuri A. Temiz, Allison M. Land, Brandon Leonard, Anurag S. Rathore, Douglas Yee and Eric W. Refsland and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Emily K. Law

20 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

APOBEC3B is an enzymatic source of mutation in breast cancer

2013 639 citations Michael B. Burns, Lela Lackey et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emily K. Law United States	16	1.2k	490	417	408	333	20	1.7k
Michael A. Carpenter United States	22	1.4k 1.1×	402 0.8×	359 0.9×	601 1.5×	436 1.3×	47	2.0k
Brandon Leonard United States	13	1.0k 0.8×	451 0.9×	445 1.1×	210 0.5×	276 0.8×	24	1.5k
Eric W. Refsland United States	9	963 0.8×	322 0.7×	273 0.7×	707 1.7×	424 1.3×	13	1.7k
Zuzana Keckesova United States	12	1.1k 0.9×	477 1.0×	1.0k 2.4×	539 1.3×	327 1.0×	15	2.3k
Rebecca M. McDougle United States	7	638 0.5×	272 0.6×	215 0.5×	243 0.6×	194 0.6×	8	949
Y. Ramanathan United States	11	1.1k 0.9×	132 0.3×	292 0.7×	365 0.9×	130 0.4×	13	1.5k
Thomas Eisenreich United States	11	902 0.7×	314 0.6×	434 1.0×	317 0.8×	269 0.8×	15	2.7k
Michelle J. West United Kingdom	21	793 0.7×	137 0.3×	663 1.6×	426 1.0×	324 1.0×	41	1.7k
Jennifer L. McCann United States	15	722 0.6×	144 0.3×	185 0.4×	227 0.6×	144 0.4×	23	1.0k
Xue F. Huang United States	20	710 0.6×	381 0.8×	587 1.4×	87 0.2×	105 0.3×	34	1.6k

Countries citing papers authored by Emily K. Law

Since Specialization

Citations

This map shows the geographic impact of Emily K. Law's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily K. Law with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily K. Law more than expected).

Fields of papers citing papers by Emily K. Law

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily K. Law. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily K. Law. The network helps show where Emily K. Law may publish in the future.

Co-authorship network of co-authors of Emily K. Law

This figure shows the co-authorship network connecting the top 25 collaborators of Emily K. Law. A scholar is included among the top collaborators of Emily K. Law based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily K. Law. Emily K. Law is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McCann, Jennifer L., Agnese Cristini, Emily K. Law, et al.. (2023). APOBEC3B regulates R-loops and promotes transcription-associated mutagenesis in cancer. Nature Genetics. 55(10). 1721–1734. 36 indexed citations

McCann, Jennifer L., Daniel J. Salamango, Emily K. Law, William L. Brown, & Reuben S. Harris. (2020). MagnEdit—interacting factors that recruit DNA-editing enzymes to single base targets. Life Science Alliance. 3(4). e201900606–e201900606. 7 indexed citations

Law, Emily K., Rena Levin-Klein, Matthew C. Jarvis, et al.. (2020). APOBEC3A catalyzes mutation and drives carcinogenesis in vivo. The Journal of Experimental Medicine. 217(12). 83 indexed citations

Starrett, Gabriel J., Artur A. Serebrenik, Jennifer L. McCann, et al.. (2019). Polyomavirus T Antigen Induces APOBEC3B Expression Using an LXCXE-Dependent and TP53-Independent Mechanism. mBio. 10(1). 32 indexed citations

Brown, William L., Emily K. Law, Prokopios P. Argyris, et al.. (2019). A Rabbit Monoclonal Antibody against the Antiviral and Cancer Genomic DNA Mutating Enzyme APOBEC3B. Antibodies. 8(3). 47–47. 28 indexed citations

McCann, Jennifer L., et al.. (2019). The DNA deaminase APOBEC3B interacts with the cell-cycle protein CDK4 and disrupts CDK4-mediated nuclear import of Cyclin D1. Journal of Biological Chemistry. 294(32). 12099–12111. 20 indexed citations

Carpenter, Michael A., Emily K. Law, Artur A. Serebrenik, William L. Brown, & Reuben S. Harris. (2018). A lentivirus-based system for Cas9/gRNA expression and subsequent removal by Cre-mediated recombination. Methods. 156. 79–84. 16 indexed citations

Law, Emily K., Anieta M. Sieuwerts, Kelly LaPara, et al.. (2016). The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer. Science Advances. 2(10). e1601737–e1601737. 160 indexed citations

Kanu, Nnennaya, Maria Antonietta Cerone, Gerald Goh, et al.. (2016). DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer. Genome biology. 17(1). 185–185. 118 indexed citations

10.

Harris, Reuben S., Emily K. Law, Kelly LaPara, et al.. (2016). Abstract S4-07: Tamoxifen resistance driven by the DNA cytosine deaminase APOBEC3B in recurrent estrogen receptor positive breast cancer. Cancer Research. 76(4_Supplement). S4–7. 1 indexed citations

11.

Starrett, Gabriel J., Elizabeth M. Luengas, Jennifer L. McCann, et al.. (2016). The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis. Nature Communications. 7(1). 12918–12918. 121 indexed citations

12.

Land, Allison M., et al.. (2015). Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV Vif. Oncotarget. 6(37). 39969–39979. 15 indexed citations

13.

Refsland, Eric W., Judd F. Hultquist, Elizabeth M. Luengas, et al.. (2014). Natural Polymorphisms in Human APOBEC3H and HIV-1 Vif Combine in Primary T Lymphocytes to Affect Viral G-to-A Mutation Levels and Infectivity. PLoS Genetics. 10(11). e1004761–e1004761. 82 indexed citations

14.

Burns, Michael B., Lela Lackey, Michael A. Carpenter, et al.. (2013). APOBEC3B is an enzymatic source of mutation in breast cancer. Nature. 494(7437). 366–370. 639 indexed citations breakdown →

15.

Lackey, Lela, Emily K. Law, William L. Brown, & Reuben S. Harris. (2013). Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination. Cell Cycle. 12(5). 762–772. 111 indexed citations

16.

Land, Allison M., Emily K. Law, Michael A. Carpenter, et al.. (2013). Endogenous APOBEC3A DNA Cytosine Deaminase Is Cytoplasmic and Nongenotoxic. Journal of Biological Chemistry. 288(24). 17253–17260. 68 indexed citations

17.

Burns, Michael B., Lela Lackey, Michael A. Carpenter, et al.. (2013). Correction: Corrigendum: APOBEC3B is an enzymatic source of mutation in breast cancer. Nature. 502(7472). 580–580. 2 indexed citations

18.

Rathore, Anurag S., Michael A. Carpenter, Özlem Demir, et al.. (2013). The Local Dinucleotide Preference of APOBEC3G Can Be Altered from 5′-CC to 5′-TC by a Single Amino Acid Substitution. Journal of Molecular Biology. 425(22). 4442–4454. 77 indexed citations

19.

Carpenter, Michael A., Ming Li, Anurag S. Rathore, et al.. (2012). Methylcytosine and Normal Cytosine Deamination by the Foreign DNA Restriction Enzyme APOBEC3A. Journal of Biological Chemistry. 287(41). 34801–34808. 111 indexed citations

20.

Lynch, Vincent J., et al.. (1990). Cytological differences between normal and malignant human cell populations in culture.. PubMed. 50(11). 3390–3. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact